The biotech is a step closer to getting its therapy for drug-resistant infections to patients.
{iframe}https://www.bizjournals.com/washington/news/2019/10/08/gaithersburg-firm-taking-down-superbugs-just.html{/iframe}
The biotech is a step closer to getting its therapy for drug-resistant infections to patients.